Innovation Analysis on Postgenomic Biomarkers: Glycomics for Chronic Diseases

OMICS A Journal of Integrative Biology

Volumn 21, Issue 4, 2017, Pages 183-196

  Adua, Eric ^a   Russell, Alyce ^a   Roberts, Peter ^a   Wang, Youxin ^b   Song, Manshu ^b   Wang, Wei ^a  

^a EDITH COWAN UNIVERSITY   (Australia)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; glycoinformatics; glycomics; innovation analysis; postgenomics biomarkers

Indexed keywords

BIOLOGICAL MARKER; GLYCAN;

ANALYSIS; CAPILLARY ELECTROPHORESIS; CARBOHYDRATE ANALYSIS; CHRONIC DISEASE; DATA BASE; DEGLYCOSYLATION; GLYCOBIOLOGY; GLYCOSYLATION; HUMAN; LIQUID CHROMATOGRAPHY; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; REVIEW; PERSONALIZED MEDICINE; PROCEDURES; PROTEOMICS;

BIOMARKERS; CHRONIC DISEASE; GLYCOMICS; GLYCOSYLATION; PRECISION MEDICINE; PROTEOMICS;

EID: 85017305574     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2017.0035     Document Type: Review

References (106)

1. Aebi M, Bernasconi R, Clerc S, and Molinari M. (2010). Nglycan structures: Recognition and processing in the ER. Trends Biochem Sci 35, 74-82.
2. Alley WR Jr., and Novotny MV. (2013). Structural glycomic analyses at high sensitivity: A decade of progress. Ann Rev Anal Chem 6, 237-265.
3. Alvarez-Manilla G, Warren NL, Abney T, et al. (2007). Tools for glycomics: Relative quantitation of glycans by isotopic permethylation using 13CH3I. Glycobiology 17, 677-687.
4. An HJ, Kronewitter SR, de Leoz MLA, and Lebrilla CB. (2009). Glycomics and disease markers. Curr Opin Chem Biol 13, 601-607.
5. An HJ, Peavy TR, Hedrick JL, and Lebrilla CB. (2003). Determination of N-glycosylation sites and site heterogeneity in glycoproteins. Anal Chem 75, 5628-5637.
6. Aoki-Kinoshita KF. (2008). An introduction to bioinformatics for glycomics research. PLoS Comput Biol 4, e1000075.
7. Aoki-Kinoshita KF. (2013). Using databases and web resources for glycomics research. Mol Cell Proteomics 12, 1036-1045.
8. Apweiler R, Hermjakob H, and Sharon N. (1999). On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1473, 4-8.
9. Arnold JN, Saldova R, Hamid UM, and Rudd PM. (2008). Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 8, 3284-3293.
10. Artemenko NV, Campbell MP, and Rudd PM. (2010). GlycoExtractor: A web-based interface for high throughput processing of HPLC-glycan data. J Proteome Res 9, 2037-2041.
11. Baycin HD, Wolozny D, Colao J, et al. (2014). Glycoproteomic and glycomic databases. Clin Proteomics 11, 1-10.
12. Bigge JC, Patel TP, Bruce JA, Goulding PN, Charles SM, and Parekh RB. (1995). Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal Biochem 230, 229-238.
13. Bindila L, and Peter-Katalinić J. (2009). Chip-mass spectrometry for glycomic studies. Mass Spectrom Rev 28, 223-253.
14. Brooks SA. (2009). Strategies for analysis of the glycosylation of proteins: Current status and future perspectives. Mol Biotechnol 43, 76-88.
15. Callewaert N, Contreras R, Mitnik-Gankin L, Carey L, Matsudaira P, and Ehrlich D. (2004). Total serum protein Nglycome profiling on a capillary electrophoresis-microfluidics platform. Electrophoresis 25, 3128-3131.
16. Campa C, Coslovi A, Flamigni A, and Rossi M. (2006). Overview on advances in capillary electrophoresis-mass spectrometry of carbohydrates: A tabulated review. Electrophoresis 27, 2027-2050.
17. Campbell MP, Royle L, Radcliffe CM, Dwek RA, and Rudd PM. (2008). GlycoBase and autoGU: Tools for HPLC-based glycan analysis. Bioinformatics 24, 1214-1216.
18. Ceroni A, Dell A, and Haslam SM. (2007). The GlycanBuilder: A fast, intuitive and flexible software tool for building and displaying glycan structures. Source Code Biol Med 2, 1-13.
19. Ceroni A, Maass K, Geyer H, Geyer R, Dell A, and Haslam SM. (2008). GlycoWorkbench: A tool for the computer-assisted annotation of mass spectra of glycans. J Proteome Res 7, 1650-1659.
20. Cummings RD, and Pierce JM. (2009). Handbook of Glycomics. 2nd ed. San Diago: Academic Press.
21. Cummings RD, and Pierce JM. (2014). The challenge and promise of glycomics. Chem Biol 21, 1-15.
22. Desantos-Garcia JL, Khalil SI, Hussein A, Hu Y, and Mechref Y. (2011). Enhanced sensitivity of LC-MS analysis of permethylated N-glycans through online purification. Electrophoresis 32, 3516-3525.
23. Doubet S, and Albersheim P. (1992). Letter to the glyco-forum CarbBank. Glycobiology 2, 505.
24. Dunn, WB, Broadhurst HJ, Atherton RG, and Griffin JL. (2011). Systems level studies of mammalian metabolomes: The roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 40, 387-426.
25. Everest-Dass AV, Briggs MT, Kaur G, Oehler MK, Hoffmann P, and Packer NH. (2016). N-glycan MALDi imaging mass spectrometry on formalin-fixed paraffin-embedded tissue enables the delineation of ovarian cancer tissues. Mol Cell Proteomics 15, 3003-3016.
26. Frank M, and Schloissnig S. (2010). Bioinformatics and molecular modeling in glycobiology. Cell Mol Life Sci 67, 2749-2772.
27. Furukawa JI, Fujitani N, and Shinohara Y. (2013). Recent advances in cellular glycomic analyses. Biomolecules 3, 198-225.
28. Fuster MM, and Esko JD. (2005). The sweet and sour of cancer: Glycans as novel therapeutic targets. Nat Rev Cancer 5, 526-542.
29. Gornik O, Wagner J, Pucić M, Knezević A, Redzić I, and Lauc G. (2009). Stability of N-glycan profiles in human plasma. Glycobiology 19, 1547-1553.
30. Grünewald S, Matthijs G, and Jaeken J. (2002). Congenital disorders of glycosylation: A review. Pediatr Res 52, 618-624.
31. Gu J, Isaji T, Xu Q, et al. (2012). Potential roles of Nglycosylation in cell adhesion. Glyconjugate 29, 599-607.
32. Hägglund P, Matthiesen R, Elortza F, et al. (2007). An enzymatic deglycosylation scheme enabling identification of core fucosylated N-glycans and O-glycosylation site mapping of human plasma proteins. J Proteome Res 6, 3021-3031.
33. Hakomori SI. (1964). A rapid permethylation of glycolipid, and polysaccharide catalyzed by methylsulfinyl carbanion in dimethyl sulfoxide. J Biochem 55, 205-208.
34. Harada Y, Hirayama H, and Suzuki T. (2015). Generation and degradation of free asparagine-linked glycans. Cell Mol Life Sci 72, 1-25.
35. Harvey DJ. (2011). Derivatization of carbohydrates for analysis by chromatography; electrophoresis and mass spectrometry. J Chromatogr 879, 1196-1225.
36. Hayes CA, Karlsson NG, Struwe WB, et al. (2011). UniCarb-DB: A database resource for glycomic discovery. Bioinformatics 27, 1343-1344.
37. Helenius A, and Aebi M. (2001). Intracellular functions of N-linked glycans. Science 291, 2364-2369.
38. Hoffmann ED, and Stroobant V. (2001). Mass Spectrometry: Principles and Applications. England: Wiley Press.
39. Hofsteenge J, Mueller DR, de Beer T, Loeffler A, Richter WJ, and Vliegenthart JF. (1994). New type of linkage between a carbohydrate and a protein: C-glycosylation of a specific tryptophan residue in human RNase Us. Biochemistry 33, 13524-13530.
40. Huffman JE, Pucić-Baković M, Klarić L, et al. (2013). Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research. Mol Cell Proteomics 13, 1598-1610.
41. HungWT, Wang SH, Chen YT, YuHM, ChenCH, and Yang WB. (2012). MALDi-TOF MS analysis of native and permethylated or benzimidazole-derivatized polysaccharides. Molecules 17, 4950-4961.
42. Jensen PH, Karlsson NG, Kolarich D, and Packer NH. (2012). Structural analysis of N-and O-glycans released from glycoproteins. Nat Protoc 7, 1299-1310.
43. Kang P, Mechref Y, Klouckova I, and Novotny MV. (2005). Solid-phase permethylation of glycans for mass spectrometric analysis. Rapid Commun Mass Spectrom 19, 3421-3428.
44. Krishnamoorthy L, and Mahal LK. (2009). Glycomic analysis: An array of technologies. ACS Chem Biol 4, 715-732.
45. Kristić J, Vucković F, Menni C, et al. (2014). Glycans are a novel biomarker of chronological and biological ages. The J Gerontol A Biol Sci Med Sci 69, 779-789.
46. Kyselova Z, Mechref Y, Al bataineh MM, et al., (2007). Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res 6, 1822-1832.
47. Lauc G. (2016). Precision medicine that transcends genomics: Glycans as integrators of genes and environment. Biochim Biophys Acta 1860, 1571-1573.
48. Lauc G, Huffman JE, Pucić M, et al. (2013). Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet 9, e1003225.
49. Lauc G, Pezer M, Rudan I, and Campbell H. (2016). Mechanisms of disease: The human N-glycome. Biochim Biophys Acta 1860, 1574-1582.
50. Lazar IM, Lee W, and Lazar AC. (2013). Glycoproteomics on the rise: Established methods, advanced techniques, sophisticated biological applications. Electrophoresis 34, 113-125.
51. Lu JP, Knezevic A, Wang YX, et al. (2011). Screening novel biomarkers for metabolic syndrome by profiling human plasma N-glycans in Chinese Han and Croatian populations. J Proteome Res 10, 4959-4969.
52. Lütteke T, Bohne Lang A, Loss A, Goetz T, Frank M, and Von der Lieth CW. (2006). GLYCOSCIENCES. de: An Internet portal to support glycomics and glycobiology research. Glycobiology 16, 71R-81R.
53. McLachlan F, Timofeeva M, Bermingham M, et al. (2016). A case-control study in an Orcadian population investigating the relationship between human plasma N-glycans and metabolic syndrome. J Glycomics lipidomics 6, 2153-0637.
54. Mechref Y. (2011). Analysis of glycans derived from glycoconjugates by capillary electrophoresis-mass spectrometry. Electrophoresis 32, 3467-3481.
55. Menni C, Keser T, Mangino M, et al. (2013). Glycosylation of immunoglobulin g: Role of genetic and epigenetic influences. PLoS One 8, e82558.
56. Merry T, and Astrautsova S. (2003). Chemical and enzymatic release of glycans from glycoproteins. Methods Mol Biol 213, 27-40.
57. Monton MR, and Terabe S. (2005). Recent developments in capillary electrophoresis-mass spectrometry of proteins and peptides. Anal Sci 21, 5-13.
58. Novotny MV, Alley WR Jr., and Mann BF. (2013). Analytical glycobiology at high sensitivity: Current approaches and directions. Glycoconj J 30, 89-117.
59. Ohtsubo K, and Marth JD. (2006). Glycosylation in cellular mechanisms of health and disease. Cell 126, 855-867.
60. Park Y, and Lebrilla CB. (2005). Application of Fourier transform ion cyclotron resonance mass spectrometry to oligosaccharides. Mass Spectrom Rev 24, 232-264.
61. Powers TW, Jones EE, Betesh LR, et al. (2013). Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues. Anal Chem 85, 9799-9806.
62. Raman R, Raguram S, Venkataraman G, Paulson JC, and Sasisekharan R. (2005). Glycomics: An integrated systems approach to structure-function relationships of glycans. Nat Methods 2, 817-824.
63. Raman R, Venkataraman M, Ramakrishnan S, Lang W, Raguram S, and Sasisekharan R. (2006). Advancing glycomics: Implementation strategies at the consortium for functional glycomics. Glycobiology 16, 82R-90R.
64. Ranzinger R, Frank M, Von der Lieth CW, and Herget S. (2009). Glycome-DB. org: A portal for querying across the digital world of carbohydrate sequences. Glycobiology 19, 1563-1567.
65. Rosnoblet C, Peanne R, Legrand D, and Foulquier F. (2013). Glycosylation disorders of membrane trafficking. Glycoconj J 30, 23-31.
66. Roth Z, Yehezkel G, and Khalaila I. (2012). Identification and quantification of protein glycosylation. Int J Carbohyd Chem 2, 1-10.
67. Royle L, Campbell MP, Radcliffe CM, et al. (2008). HPLCbased analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem 376, 1-12.
68. Rudd PM, Colominas C, Royle L, et al. (2001). A high-performance liquid chromatography based strategy for rapid, sensitive sequencing of N-linked oligosaccharide modifications to proteins in sodium dodecyl sulphate polyacrylamide electrophoresis gel bands. Proteomics 1, 285-294.
69. Ruhaak L, Zauner G, Huhn C, Bruggink C, Deelder A, and Wuhrer M. (2010). Glycan labeling strategies and their use in identification and quantification. Anal Bioanal Chem 397, 3457-3481.
70. Russell AC, Simurina M, Garcia MT, et al., (2017). The Nglycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease. Glycobiology, in press.
71. Saldova R, Arnold J, and Rudd P. (2011). Glycobiomarkers and new technologies for the detection of lung cancer. Clin Lab Int 35, 20-23.
72. Saldova R, Asadi Shehni A, Haakensen VD, et al. (2014). Association of N-glycosylation with breast carcinoma and systemic features using high-resolution quantitative UPLC. J Proteome Res 13, 2314-2327.
73. Schachter H. (2000). The joys of HexNAc. The synthesis and function of N-and O-glycan branches. Glycoconj J 17, 465-483.
74. Schwedler C, Kaup M, Weiz S, et al. (2014). Identification of 34 N-glycan isomers in human serum by capillary electrophoresis coupled with laser-induced fluorescence allows improving glycan biomarker discovery. Anal Bioanal Chem 406, 7185-7193.
75. Sebastian A, Alzain MA, Asweto CO, et al. (2016). Glycan biomarkers for rheumatoid arthritis and its remission status in han Chinese patients. OMICS: J Integrative Biol 20, 343-351.
76. Song X, Ju H, Zhao C, and Lasanajak Y. (2014). Novel strategy to release and tag N-glycans for functional glycomics. Bioconj Chem 25, 1881-1887.
77. Stanley P. (2011). Golgi glycosylation. Cold Spring Harb. Perspect. Biol 3, a005199.
78. Stöckmann H, Carta G, McManus CA, Hilliard M, and Rudd PM. (2013). High-throughput workflow for glycan profiling and characterisation. The Beilstein Glyco-Bioinformatics symposium, Germany.
79. Taniguchi N, Honke K, and Fukuda M. (2011). Handbook of Glycosyltransferases and Related Genes. 2nd ed. Springer Science & Business Media, Japan.
80. Tarentino AL, Trimble RB, and Plummer TH Jr. (1989). Enzymatic approaches for studying the structure, synthesis, and processing of glycoproteins. Methods Cell Biol 32, 111-139.
81. Taylor ME, and Drickamer K. (2011). Introduction to Glycobiology. 2nd ed. Oxford University Press, London.
82. Testa R, Vanhooren V, Bonfigli AR, et al. (2015). N-glycomic changes in serum proteins in type 2 diabetes mellitus correlate with complications and with metabolic syndrome parameters. PLoS One 10, e0119983.
83. Toghi Eshghi S, Yang S, Wang X, Shah P, Li X, and Zhang H. (2014). Imaging of N-linked glycans from formalin-fixed paraffin-embedded tissue sections using MALDi mass spectrometry. ACS Chem Biol 9, 2149-2156.
84. Tomiya N, Narang S, Lee YC, and Betenbaugh MJ. (2004). Comparing N-glycan processing in mammalian cell lines to native and engineered lepidopteran insect cell lines. Glycoconjugate J 21, 343-360.
85. Turnbull JE, and Field RA. (2007). Emerging glycomics technologies. Nat Chem Biol 3, 74-77.
86. Varadi C, Mittermayr S, Szekrenyes A, et al. (2013). Analysis of haptoglobin N-glycome alterations in inflammatory and malignant lung disease by capillary electrophoresis. Electrophoresis 34, 2287-2294.
87. Varki A, Cummings RD, Esko JD, et al. (2009a). Symbol nomenclature for glycan representation. Proteomics 9, 5398-5399.
88. Varki A, Esko Jeffery D, Freeze HH, et al. (2009b). Essentials of Glycobiology. 2nd ed. New York: Cold Spring Habour.
89. Von der Lieth CW, Bohne-Lang A, Lohmann KK, and Frank M. (2004). Bioinformatics for glycomics: Status, methods, requirements and perspectives. Brief Bioinform 5, 164-178.
90. Von der Lieth CW, Freire AA, Blank D, et al. (2011). EUROCarbDB: An open-access platform for glycoinformatics. Glycobiology 21, 493-502.
91. Vucković F, Kristić J, Gudelj I, et al. (2015). Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome. Arthritis Rheumatol 67, 2978-2989.
92. Walker SH, Lilley LM, Enamorado MF, Comins DL, and Muddiman DC. (2011). Hydrophobic derivatization of Nlinked glycans for increased ion abundance in electrospray ionization mass spectrometry. J Am Soc Mass Spectrom 22, 1309-1317.
93. Wang W. (2013). Validation and development of N-glycan as biomarker in cancer diagnosis. Curr Pharmacogenomics Person Med 11, 53-58.
94. Wang Y, Adua E, Russell A, et al. (2016a). Glycomics and its application potential in precision medicine in China. Science/ AAAS 354, 36-39.
95. Wang Y, Klaric L, Yu X, et al. (2016b). The association between glycosylation of immunoglobulin G and hypertension: A multiple ethnic cross-sectional study. Medicine 95, e3379.
96. Watanabe T, Inoue N, Kutsukake T, Matsuki S, and Takeuchi M. (2000). Labeling conditions using a 2-aminobenzamide reagent for quantitative analysis of sialo-oligosaccharides. Biol Pharm Bull 23, 269-273.
97. Weerapana E, and Imperiali B. (2006). Asparagine-linked protein glycosylation: From eukaryotic to prokaryotic systems. Glycobiology 16, 91R-101R.
98. Weiskopf AS, Vouros P, and Harvey DJ. (1998). Electrospray ionization-ion trap mass spectrometry for structural analysis of complex N-linked glycoprotein oligosaccharides. Anal Chem 70, 4441-4447.
99. Wuhrer M. (2013). Glycomics using mass spectrometry. Glycoconj J 30, 11-22.
100. Xia B, Kawar ZS, Ju T, Alvarez RA, Sachdev GP, and Cummings RD. (2005). Versatile fluorescent derivatization of glycans for glycomic analysis. Nat Methods 2, 845-850.
101. Yang S, Rubin A, Eshghi ST, and Zhang H. (2016). Chemoenzymatic method for glycomics: Isolation, identification, and quantitation. Proteomics 16, 241-256.
102. Yu X, Wang Y, Kristic J, et al. (2016). Profiling IgG N-glycans as potential biomarker of chronological and biological ages: A community-based study in a Han Chinese population. Medicine 95, e4112.
103. Zaia J. (2008). Mass spectrometry and the emerging field of glycomics. Chem Biol 15, 881-892.
104. Zauner G, Deelder AM, and Wuhrer M. (2011). Recent advances in hydrophilic interaction liquid chromatography (HILIC) for structural glycomics. Electrophoresis 32, 3456-3466.
105. Zhao SS, Zhong X, Tie C, and Chen DD. (2012). Capillary electrophoresis-mass spectrometry for analysis of complex samples. Proteomics 12, 2991-3012.
106. Zoldos V, Horvat T, and Lauc G. (2013). Glycomics meets genomics, epigenomics and other high throughput omics for system biology studies. Curr Opin Chem Biol 17, 34-40.